Target- |
MechanismCell wall inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 2005 |
100 Clinical Results associated with Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd.
100 Deals associated with Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd.